1. Home
  2. CDTX vs RBKB Comparison

CDTX vs RBKB Comparison

Compare CDTX & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • RBKB
  • Stock Information
  • Founded
  • CDTX 2012
  • RBKB 1860
  • Country
  • CDTX United States
  • RBKB United States
  • Employees
  • CDTX N/A
  • RBKB N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • RBKB Banks
  • Sector
  • CDTX Health Care
  • RBKB Finance
  • Exchange
  • CDTX Nasdaq
  • RBKB Nasdaq
  • Market Cap
  • CDTX 79.3M
  • RBKB 92.6M
  • IPO Year
  • CDTX 2015
  • RBKB 2019
  • Fundamental
  • Price
  • CDTX $14.37
  • RBKB $9.63
  • Analyst Decision
  • CDTX Strong Buy
  • RBKB
  • Analyst Count
  • CDTX 5
  • RBKB 0
  • Target Price
  • CDTX $30.50
  • RBKB N/A
  • AVG Volume (30 Days)
  • CDTX 21.1K
  • RBKB 7.5K
  • Earning Date
  • CDTX 11-07-2024
  • RBKB 10-24-2024
  • Dividend Yield
  • CDTX N/A
  • RBKB N/A
  • EPS Growth
  • CDTX N/A
  • RBKB N/A
  • EPS
  • CDTX N/A
  • RBKB N/A
  • Revenue
  • CDTX $44,653,000.00
  • RBKB $29,243,000.00
  • Revenue This Year
  • CDTX N/A
  • RBKB N/A
  • Revenue Next Year
  • CDTX N/A
  • RBKB N/A
  • P/E Ratio
  • CDTX N/A
  • RBKB N/A
  • Revenue Growth
  • CDTX 19.60
  • RBKB N/A
  • 52 Week Low
  • CDTX $10.00
  • RBKB $6.10
  • 52 Week High
  • CDTX $24.40
  • RBKB $9.81
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 72.85
  • RBKB 65.77
  • Support Level
  • CDTX $12.89
  • RBKB $9.46
  • Resistance Level
  • CDTX $13.78
  • RBKB $9.74
  • Average True Range (ATR)
  • CDTX 0.70
  • RBKB 0.25
  • MACD
  • CDTX 0.13
  • RBKB 0.04
  • Stochastic Oscillator
  • CDTX 75.31
  • RBKB 87.67

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.

Share on Social Networks: